cyclosporine ophthalmic emulsion 0.05%

Building on cyclosporine for dry eyeA phase II study investigating a novel topical cyclosporine product (CyclASol, Novaliq) formulated in a semifluorinated alkane (SFA) vehicle showed promising efficacy, safety, and tolerability. Planning is ongoing for the phase III trial of cyclosporine in the SFA technology.
3 steps to improve ocular health of dry eye patientsPatients with dry eye can be kept healthy—and happy—by diagnosing properly, following specific treatment plans, and providing excellent communication.
Allergy or dry eye: Which is it?Ocular surface disease may be multifactorial, presenting a challenge to the physician in making a correct diagnosis and management plan.
Prepping patients for success on therapy for their CDEChronic dry eye is underdiagnosed and undertreated, but careful observation, good listening skills, and proven treatment approaches can help patients achieve better vision.